SuperworthGeneDx shares outstanding WGS
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 29.7M
- On a year earlier
- −0.1%
- fewer shares
GeneDx had 29.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is about the same as a year earlier.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 29M | +5% |
| FY2024 | 27.8M | +7% |
| FY2023 | 25.9M | +121% |
| FY2022 | 11.7M | +60% |
| FY2021 | 7.3M | +445% |
| FY2020 | 1.3M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 29.7M | −0% | |
| Q1 FY26 | 29.3M | +4% | |
| Q4 FY25 | 29M | +5% | |
| Q3 FY25 | 28.8M | +6% | |
| Q2 FY25 | 29.8M | +12% | |
| Q1 FY25 | 28.1M | +8% | |
| Q4 FY24 | 27.8M | +7% | |
| Q3 FY24 | 27.1M | +5% | |
| Q2 FY24 | 26.6M | +5% | |
| Q1 FY24 | 26.1M | +30% | |
| Q4 FY23 | 25.9M | +121% | |
| Q3 FY23 | 25.8M | +124% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on GeneDx
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.